E-LIB Suche - Ergebnisse für: PACE PALITTI V

1

OC.05.7: CHOLESTASIS IMPACTS ON PERFORMANCE OF NON INVASIVE..:

Calvaruso, V. ; Celsa, C. ; Cristoferi, L....
Digestive and Liver Disease. 56 (2024) - p. S153-S154 , 2024

Link: https://doi.org/10.1016/..

2

Longer transplant-free and liver-related event-free surviva..:

Terracciani, F. ; De Vincentis, A. ; D'Amato, D....
Digestive and Liver Disease. 56 (2024) - p. S3-S5 , 2024

Link: https://doi.org/10.1016/..

3

Characterization of resistance profiles in HCV 2-3-4 DAA-na..:

Barbaliscia, S. ; Di Maio, V.C. ; Teti, E....
Digestive and Liver Disease. 50 (2018) 1 - p. 46-47 , 2018

Link: https://doi.org/10.1016/..

4

Natural HCV resistance is common in Italy and differently a..:

Sorbo, M.C. ; Cento, V. ; Bertoli, A....
Digestive and Liver Disease. 49 (2017) 1 - p. e52 , 2017

Link: https://doi.org/10.1016/..

5

Daclatasvir/sofosbuvir and ribavirin 800mg flat dose is hig..:

Pellicelli, A. ; Messina, V. ; Tarquini, P....
Digestive and Liver Disease. 49 (2017) 1 - p. e64 , 2017

Link: https://doi.org/10.1016/..

6

Prevalence and characteristics of resistance associated sub..:

Di Maio, V.C. ; Barbaliscia, S. ; Lenci, I....
Digestive and Liver Disease. 49 (2017) 1 - p. e62-e63 , 2017

Link: https://doi.org/10.1016/..

7

Impact of different Sofosbuvir-based direct acting antivira..:

Pellicelli, A.M. ; Pace Palitti, V. ; Vignally, P....
Digestive and Liver Disease. 48 (2016) - p. e42 , 2016

Link: https://doi.org/10.1016/..

8

Cholestasis impacts on performance of non invasive tests fo..:

Calvaruso, V. ; Celsa, C. ; Cristoferi, L....
Digestive and Liver Disease. 56 (2024) - p. S28 , 2024

Link: https://doi.org/10.1016/..

9

Prevalence and Characterization of Resistance Profiles of "..:

Khalili, O. El ; Chenwi, C. ; Di Maio, V.C....
Digestive and Liver Disease. 56 (2024) - p. S35-S36 , 2024

Link: https://doi.org/10.1016/..

10

Long-term results from the Italian real-world experience on..:

Terracciani, F. ; De Vincentis, A. ; D'Amato, D....
Digestive and Liver Disease. 55 (2023) - p. S44-S45 , 2023

Link: https://doi.org/10.1016/..

11

Prediction of response to obeticholic acid in primary bilia..:

De Vincentis, A. ; Terracciani, F. ; D'Amato, D....
Digestive and Liver Disease. 55 (2023) - p. S4-S5 , 2023

Link: https://doi.org/10.1016/..

12

VIRONET-C real life experience of resistance-guided retreat..:

Di Maio, V.C. ; Aragri, M. ; Masetti, C....
Digestive and Liver Disease. 52 (2020) - p. e2-e3 , 2020

Link: https://doi.org/10.1016/..

13

Analysis of resistance and phylogenetic clusters in HCV-2c ..:

Barbaliscia, S. ; Di Maio, V.C. ; Fabeni, L....
Digestive and Liver Disease. 52 (2020) - p. e24-e25 , 2020

Link: https://doi.org/10.1016/..

14

Characterization of baseline factors associated with treatm..:

Barbaliscia, S. ; Di Maio, V.C. ; Teti, E....
Digestive and Liver Disease. 51 (2019) - p. e65-e66 , 2019

Link: https://doi.org/10.1016/..

15

Resistance test guided retreatment of HCV infected patients..:

Di Maio, V.C. ; Aragri, M. ; Masetti, C....
Digestive and Liver Disease. 51 (2019) - p. e53-e54 , 2019

Link: https://doi.org/10.1016/..